Q1 2022 EPS Estimates for CNO Financial Group, Inc. (NYSE:CNO) Increased by Jefferies Financial Group

CNO Financial Group, Inc. (NYSE:CNO – Get Rating) – Stock analysts at Jefferies Financial Group lifted their Q1 2022 earnings per share (EPS) estimates for CNO Financial Group in a report issued on Monday, March 14th. Jefferies Financial Group analyst D. Bergman now forecasts that the financial services provider will post earnings of $0.63 per share for the quarter, up from their prior estimate of $0.60. Jefferies Financial Group currently has a “Hold” rating and a $25.00 target price on the stock. Jefferies Financial Group also issued estimates for CNO Financial Group’s Q2 2022 earnings at $0.57 EPS, Q3 2022 earnings at $0.58 EPS, Q4 2022 earnings at $0.57 EPS, FY2022 earnings at $2.35 EPS, Q2 2023 earnings at $0.60 EPS, Q3 2023 earnings at $0.63 EPS, Q4 2023 earnings at $0.63 EPS, FY2023 earnings at $2.50 EPS, FY2024 earnings at $2.75 EPS, FY2025 earnings at $3.00 EPS and FY2026 earnings at $3.30 EPS.

Several other equities analysts also recently issued reports on CNO. Piper Sandler downgraded CNO Financial Group from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $29.00 to $27.00 in a research report on Wednesday, January 5th. B. Riley reissued a “buy” rating on shares of CNO Financial Group in a report on Friday, March 4th. Morgan Stanley boosted their target price on CNO Financial Group from $27.00 to $28.00 and gave the stock an “equal weight” rating in a report on Friday, January 7th. Finally, Zacks Investment Research raised CNO Financial Group from a “hold” rating to a “buy” rating and set a $24.00 target price on the stock in a report on Tuesday, December 21st. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, CNO Financial Group has a consensus rating of “Hold” and an average price target of $25.80.

(Ad)

🍄Fungi: Oregon voted in 2020 to pass the Psilocybin Program Initiative, allowing psilocybin (the active compound in “magic mushrooms”) for therapeutic uses. Now companies like Ei. Ventures are testing psilocybin-based therapies in pre-clinical trials. Pretty cool!

Shares of NYSE CNO opened at $24.65 on Thursday. The company has a current ratio of 0.21, a quick ratio of 0.21 and a debt-to-equity ratio of 0.54. The stock has a 50 day simple moving average of $24.76 and a 200-day simple moving average of $24.45. The company has a market cap of $2.92 billion, a PE ratio of 7.34 and a beta of 1.25. CNO Financial Group has a 12-month low of $21.88 and a 12-month high of $27.89. CNO Financial Group (NYSE:CNO – Get Rating) last issued its quarterly earnings data on Tuesday, February 8th. The financial services provider reported $0.87 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.59 by $0.28. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $906.40 million. CNO Financial Group had a return on equity of 7.07% and a net margin of 10.70%. The business’s revenue was down .1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.57 earnings per share.

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Fuller & Thaler Asset Management Inc. increased its holdings in shares of CNO Financial Group by 2.5% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,999,775 shares of the financial services provider’s stock valued at $166,875,000 after buying an additional 171,648 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of CNO Financial Group by 486.5% in the fourth quarter. JPMorgan Chase & Co. now owns 6,984,494 shares of the financial services provider’s stock valued at $166,510,000 after buying an additional 5,793,528 shares in the last quarter. Paradice Investment Management LLC increased its holdings in shares of CNO Financial Group by 4.9% in the third quarter. Paradice Investment Management LLC now owns 4,595,840 shares of the financial services provider’s stock valued at $108,186,000 after buying an additional 214,908 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of CNO Financial Group by 17.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 3,091,418 shares of the financial services provider’s stock valued at $73,699,000 after buying an additional 451,825 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its holdings in shares of CNO Financial Group by 2.4% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,959,351 shares of the financial services provider’s stock valued at $70,550,000 after buying an additional 70,503 shares in the last quarter. 95.55% of the stock is currently owned by institutional investors.

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 24th. Shareholders of record on Thursday, March 10th will be issued a $0.13 dividend. The ex-dividend date is Wednesday, March 9th. This represents a $0.52 annualized dividend and a dividend yield of 2.11%. CNO Financial Group’s dividend payout ratio is currently 15.48%.

CNO Financial Group Company Profile (Get Rating)

CNO Financial Group, Inc is an insurance holding company, which engages in developing, marketing, and administering health insurance, annuity, individual life insurance and other insurance products. It operates through the following segments: Bankers Life, Washington National, and Colonial Penn. The Bankers Life segment markets and distributes medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents and sales managers supported by a network of community-based sales offices.

Read More

Earnings History and Estimates for CNO Financial Group (NYSE:CNO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in CNO Financial Group right now?

Before you consider CNO Financial Group, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and CNO Financial Group wasn’t on the list.

While CNO Financial Group currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 

https://www.marketbeat.com/instant-alerts/nyse-cno-analyst-earnings-estimates-2022-03-2/

Next Post

Earn $3,000 in Monthly Retirement Dividends With 3 Easy Steps | Smart Change: Personal Finance

Sat Mar 19 , 2022
(Stefon Walters) One of the best ways to ensure you’re comfortable in retirement is to put yourself in a position to have steady income coming in. While Social Security is a great supplement, for many people, it won’t suffice as the primary income source. When done the right way, dividend […]